Aventis Pharma Limited has posted a phenomenal increase in net profit for the period Q1 (ending Mar 2011) of the current fiscal (FY11). During the said quarter, net profit rises 40.16% to Rs 50.6 crore in comparison to the Rs 36.1 crore of Q1 (ending Mar 10) of previous year (FY10). Ventis Pharma Limited provides medicines for the treatment of patients in several therapeutic areas, such as cardiovascular disease, thrombotic diseases, metabolic disorders, oncology, disorders of the central nervous system, internal medicine
The company has informed the share market (BSE/NSE) that the net sales increased 6.73% to Rs 276.3 crore in quarter ended Mar 2011 when compared with the last years same quarter ended Mar 2010 which was Rs 251.4 crore.
The board of directors recommended a final dividend of Rs 23 per share (130% on face value of Rs 10). The board had also recommended a special one-time dividend of Rs. 28 per equity share of Rs. 10.
Share’s Data :-
BSE Code : 500674
Mkt. Cap : Rs 4,588.50 Crores
Aventis Pharma Ltd. share’s CMP is Rs 1,996.40 on 26th Apr 2011.
Stay tuned to BelltheBull Blog for more news on Aventis Pharma Limited !Google+